PulseAugur
实时 07:42:53
English(EN) ByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom

字节跳动剥离出的Anew Labs融资2.9亿美元用于AI药物发现

Anew Labs,字节跳动的原部门,已获得2.9亿美元融资,估值15亿美元。这家总部位于上海的AI药物发现公司此轮融资得到了包括HSG(前身为Sequoia China)、IDG资本和5Y Capital在内的知名风险投资公司的支持。Anew Labs利用AI模型进行生物分子结构预测和设计,包括其自有的AnewFold模型以及Google DeepMind的AlphaFold 3的开源版本。 AI

影响 加速AI在药物设计中的作用,并标志着投资者对AI驱动的制药创新的强烈信心。

排序理由 AI药物发现初创公司获得巨额融资。 [lever_c_demoted from significant: ic=1 ai=0.7]

在 SCMP — Tech 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →

字节跳动剥离出的Anew Labs融资2.9亿美元用于AI药物发现

本文如何被排名

Signal score
9 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
AI药物发现初创公司获得巨额融资。 [lever_c_demoted from significant: ic=1 ai=0.7]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
funding, product, model release
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
Breaking (< 6h)
Fresh story with cross-source coverage still developing. Ranking may shift as more sources report.

完整方法见我们的编辑标准

报道来源 [1]

  1. SCMP — Tech TIER_1 English(EN) · Xinmei Shen ·

    字节跳动旗下Anu Labs融资2.9亿美元,AI药物研发公司迎来融资热潮

    China is seeing a fresh fundraising boom for artificial intelligence-powered drug developers, with start-ups including a ByteDance spin-off raising hundreds of millions of dollars this week as investors rush to back domestic challengers to Anthropic and Isomorphic Labs. Anew Labs…